LIVANOVA PLC (LIVN) Stock Fundamental Analysis
USA - NASDAQ:LIVN - GB00BYMT0J19 - Common Stock
53.34 USD
-0.52 (-0.97%)
53.34 USD
0 (0%)
LIVN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. LIVN has only an average score on both its financial health and profitability. LIVN scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
LIVN had positive earnings in the past year.
In the past year LIVN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: LIVN reported negative net income in multiple years.
Of the past 5 years LIVN 4 years had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of -8.43%, LIVN is doing good in the industry, outperforming 63.49% of the companies in the same industry.
The Return On Equity of LIVN (-18.82%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 8.04%, LIVN belongs to the top of the industry, outperforming 86.77% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for LIVN is significantly below the industry average of 9.01%.
The last Return On Invested Capital (8.04%) for LIVN is above the 3 year average (3.45%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.43% | ||
| ROE | -18.82% | ||
| ROIC | 8.04% |
ROA(3y)-0.17%
ROA(5y)-4.24%
ROE(3y)-0.33%
ROE(5y)-8.58%
ROIC(3y)3.45%
ROIC(5y)N/A
1.3 Margins
LIVN has a Operating Margin of 14.41%. This is amongst the best in the industry. LIVN outperforms 83.60% of its industry peers.
In the last couple of years the Operating Margin of LIVN has grown nicely.
LIVN has a better Gross Margin (69.07%) than 76.72% of its industry peers.
LIVN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.41% | ||
| PM (TTM) | N/A | ||
| GM | 69.07% |
OM growth 3Y41.76%
OM growth 5Y18.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
2. Health
2.1 Basic Checks
LIVN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for LIVN has been increased compared to 1 year ago.
Compared to 5 years ago, LIVN has more shares outstanding
The debt/assets ratio for LIVN is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.49, we must say that LIVN is in the distress zone and has some risk of bankruptcy.
LIVN has a Altman-Z score (1.49) which is in line with its industry peers.
The Debt to FCF ratio of LIVN is 2.66, which is a good value as it means it would take LIVN, 2.66 years of fcf income to pay off all of its debts.
LIVN has a better Debt to FCF ratio (2.66) than 87.83% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that LIVN is not too dependend on debt financing.
LIVN has a Debt to Equity ratio (0.31) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 2.66 | ||
| Altman-Z | 1.49 |
ROIC/WACC0.94
WACC8.59%
2.3 Liquidity
LIVN has a Current Ratio of 1.29. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
LIVN's Current ratio of 1.29 is on the low side compared to the rest of the industry. LIVN is outperformed by 78.84% of its industry peers.
A Quick Ratio of 1.09 indicates that LIVN should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.09, LIVN is doing worse than 73.02% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.09 |
3. Growth
3.1 Past
LIVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.66%, which is quite good.
LIVN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.82% yearly.
The Revenue has grown by 8.23% in the past year. This is quite good.
The Revenue has been growing slightly by 2.94% on average over the past years.
EPS 1Y (TTM)11.66%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%12.9%
Revenue 1Y (TTM)8.23%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%10.64%
3.2 Future
Based on estimates for the next years, LIVN will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.46% on average per year.
LIVN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.61% yearly.
EPS Next Y13.5%
EPS Next 2Y11.34%
EPS Next 3Y10.39%
EPS Next 5Y11.46%
Revenue Next Year8.58%
Revenue Next 2Y8.2%
Revenue Next 3Y7.55%
Revenue Next 5Y5.61%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 14.65, which indicates a correct valuation of LIVN.
Based on the Price/Earnings ratio, LIVN is valued cheaper than 86.77% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.76. LIVN is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 12.77, which indicates a correct valuation of LIVN.
88.89% of the companies in the same industry are more expensive than LIVN, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of LIVN to the average of the S&P500 Index (22.63), we can say LIVN is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.65 | ||
| Fwd PE | 12.77 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LIVN is valued cheaply inside the industry as 85.19% of the companies are valued more expensively.
LIVN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. LIVN is cheaper than 87.83% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.97 | ||
| EV/EBITDA | 11.98 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of LIVN may justify a higher PE ratio.
PEG (NY)1.09
PEG (5Y)8.07
EPS Next 2Y11.34%
EPS Next 3Y10.39%
5. Dividend
5.1 Amount
No dividends for LIVN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
53.34
-0.52 (-0.97%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners103.79%
Inst Owner Change-0.56%
Ins Owners0.28%
Ins Owner Change3.6%
Market Cap2.91B
Revenue(TTM)1.31B
Net Income(TTM)-211317000
Analysts82.5
Price Target64.9 (21.67%)
Short Float %3.56%
Short Ratio3.68
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.73%
Min EPS beat(2)13.16%
Max EPS beat(2)20.31%
EPS beat(4)3
Avg EPS beat(4)13.91%
Min EPS beat(4)-0.89%
Max EPS beat(4)23.08%
EPS beat(8)7
Avg EPS beat(8)17.82%
EPS beat(12)11
Avg EPS beat(12)17.01%
EPS beat(16)14
Avg EPS beat(16)16.29%
Revenue beat(2)2
Avg Revenue beat(2)3.38%
Min Revenue beat(2)2.76%
Max Revenue beat(2)4.01%
Revenue beat(4)3
Avg Revenue beat(4)1.98%
Min Revenue beat(4)-2.64%
Max Revenue beat(4)4.01%
Revenue beat(8)7
Avg Revenue beat(8)2.85%
Revenue beat(12)11
Avg Revenue beat(12)3.36%
Revenue beat(16)13
Avg Revenue beat(16)2.63%
PT rev (1m)0%
PT rev (3m)3.92%
EPS NQ rev (1m)-0.36%
EPS NQ rev (3m)1.38%
EPS NY rev (1m)0.03%
EPS NY rev (3m)2.88%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)3.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.92%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.65 | ||
| Fwd PE | 12.77 | ||
| P/S | 2.22 | ||
| P/FCF | 17.97 | ||
| P/OCF | 13.45 | ||
| P/B | 2.59 | ||
| P/tB | 32.24 | ||
| EV/EBITDA | 11.98 |
EPS(TTM)3.64
EY6.82%
EPS(NY)4.18
Fwd EY7.83%
FCF(TTM)2.97
FCFY5.57%
OCF(TTM)3.97
OCFY7.44%
SpS23.98
BVpS20.56
TBVpS1.65
PEG (NY)1.09
PEG (5Y)8.07
Graham Number41.04
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.43% | ||
| ROE | -18.82% | ||
| ROCE | 11.23% | ||
| ROIC | 8.04% | ||
| ROICexc | 12.44% | ||
| ROICexgc | 252.77% | ||
| OM | 14.41% | ||
| PM (TTM) | N/A | ||
| GM | 69.07% | ||
| FCFM | 12.38% |
ROA(3y)-0.17%
ROA(5y)-4.24%
ROE(3y)-0.33%
ROE(5y)-8.58%
ROIC(3y)3.45%
ROIC(5y)N/A
ROICexc(3y)4.13%
ROICexc(5y)N/A
ROICexgc(3y)10.29%
ROICexgc(5y)N/A
ROCE(3y)4.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y4.42%
ROICexc growth 3Y38.42%
ROICexc growth 5Y24.6%
OM growth 3Y41.76%
OM growth 5Y18.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
F-Score6
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 2.66 | ||
| Debt/EBITDA | 1.5 | ||
| Cap/Depr | 126.11% | ||
| Cap/Sales | 4.16% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 93.41% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.09 | ||
| Altman-Z | 1.49 |
F-Score6
WACC8.59%
ROIC/WACC0.94
Cap/Depr(3y)78.91%
Cap/Depr(5y)67.73%
Cap/Sales(3y)3.13%
Cap/Sales(5y)3.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.66%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%12.9%
EPS Next Y13.5%
EPS Next 2Y11.34%
EPS Next 3Y10.39%
EPS Next 5Y11.46%
Revenue 1Y (TTM)8.23%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%10.64%
Revenue Next Year8.58%
Revenue Next 2Y8.2%
Revenue Next 3Y7.55%
Revenue Next 5Y5.61%
EBIT growth 1Y77.01%
EBIT growth 3Y51.09%
EBIT growth 5Y22.46%
EBIT Next Year34.28%
EBIT Next 3Y14.67%
EBIT Next 5Y3.21%
FCF growth 1Y465.94%
FCF growth 3Y20.82%
FCF growth 5YN/A
OCF growth 1Y278.91%
OCF growth 3Y21.3%
OCF growth 5YN/A
LIVANOVA PLC / LIVN FAQ
Can you provide the ChartMill fundamental rating for LIVANOVA PLC?
ChartMill assigns a fundamental rating of 5 / 10 to LIVN.
What is the valuation status for LIVN stock?
ChartMill assigns a valuation rating of 7 / 10 to LIVANOVA PLC (LIVN). This can be considered as Undervalued.
How profitable is LIVANOVA PLC (LIVN) stock?
LIVANOVA PLC (LIVN) has a profitability rating of 6 / 10.
What is the valuation of LIVANOVA PLC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for LIVANOVA PLC (LIVN) is 14.65 and the Price/Book (PB) ratio is 2.59.
How financially healthy is LIVANOVA PLC?
The financial health rating of LIVANOVA PLC (LIVN) is 4 / 10.